Advocacy Committee

1. Annually, identify current and emerging legislative and advocacy areas of interest to the Federation and recommend strategies for FASEB engagement, with approval by the Board of Directors. 

2. Direct Federation efforts to advocate for federal research funding and other issues related to biological and biomedical research. Provide input on projects and activities to demonstrate the conduct, communication, use, and impact of the federal investment in biological and biomedical research to policymakers and the public. 

3. Develop statements, letters, congressional testimony, and other correspondence on federal legislative issues related to Federation priorities. 

4. Oversee and provide guidance on the development of resources to provide advocacy training for the biological and Biomedical research community. 

5. Coordinate consensus efforts (e.g., strategies, position papers, reports, etc.) within FASEB and its member societies pertaining to Board-approved legislative and advocacy priorities. 

6. Develop mechanisms for consulting with FASEB's Affiliate members to assess their advocacy needs and priorities and lead efforts to ensure their engagement in and collaboration with the federation's advocacy activities. 

---

Advocacy Committee Charter

Advocacy Committee Position Description 

---

 2026/2027 Roster

Melanie Scott, MD, PhD (FASEB)
Kelsey McKillip, PhD (ASIP)
Hazel L. Sive, PhD (SDB)
James Paulson, PhD (SfG)
Mike Friedlander, PhD (SEBM)
Dario Vitturi, PhD (SfRBM)
Sebastien Fuchs, MD, PhD (AFMR)
Kalev Freeman, MD, PHD (SHOCK)
Judith Yanowitz, PhD (GSA)
Peter Winsauer, PhD (ASPET)
Ariella Shikanov (SSR)

Michael Lehman, PhD, FASEB President
Darla Henderson, PhD, Executive Director
Ellen Kuo, Esq., Director, Legislative Affairs
Kathryn Storm, Executive Administrator
Meg Thompson, Federal Science Partners
Allison Hays, Federal Science Partners